about
The antitumor immune response in HER-2 positive, metastatic breast cancer patients.Does the act of surgery provoke activation of "latent" metastases in early breast cancer?Restoring Lost Anti-HER-2 Th1 Immunity in Breast Cancer: A Crucial Role for Th1 Cytokines in Therapy and PreventionProgress in the clinical detection of heterogeneity in breast cancerSurgery triggers outgrowth of latent distant disease in breast cancer: an inconvenient truth?Identifying ultrasound and clinical features of breast cancer molecular subtypes by ensemble decision.Neuregulin-1 regulates cell adhesion via an ErbB2/phosphoinositide-3 kinase/Akt-dependent pathway: potential implications for schizophrenia and cancer.Bevacizumab and breast cancer: current therapeutic progress and future perspectivesInhibition of Integrin-HER2 signaling by Cucurbitacin B leads to in vitro and in vivo breast tumor growth suppressionDifferential expression of VEGFR2 protein in HER2 positive primary human breast cancer: potential relevance to anti-angiogenic therapies.Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models.Improved tumor vascular function following high-dose epidermal growth factor receptor tyrosine kinase inhibitor therapy.HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies.Tumor angiogenesis as a target for dietary cancer preventionSoy isoflavones and cancer prevention.Expression of c-erbB-2 and glutathione S-transferase-pi in hepatocellular carcinoma and its adjacent tissue.Pivotal role of vascular endothelial growth factor pathway in tumor angiogenesis.MRI methods for evaluating the effects of tyrosine kinase inhibitor administration used to enhance chemotherapy efficiency in a breast tumor xenograft modelTherapeutic antibodies against cancer.Prognostic Significance of Transverse Relaxation Rate (R2*) in Blood Oxygenation Level-Dependent Magnetic Resonance Imaging in Patients with Invasive Breast Cancer.Dynamic Contrast-Enhanced MRI Perfusion Parameters as Imaging Biomarkers of Angiogenesis.The potential utility of acetyltanshinone IIA in the treatment of HER2-overexpressed breast cancer: Induction of cancer cell death by targeting apoptotic and metabolic signaling pathwaysPrognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy.Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers.Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axisSerological diagnosis of liver metastasis in patients with breast cancer.Potential of Diffusion-Weighted Imaging in the Characterization of Malignant, Benign, and Healthy Breast Tissues and Molecular Subtypes of Breast Cancer.Activation of the epidermal growth factor receptor promotes lymphangiogenesis in the skin.HER2-siRNA delivered by EGFR-specific single chain antibody inhibits NSCLC cell proliferation and tumor growth.Human epidermal growth factor receptor 3 (HER3) blockade with U3-1287/AMG888 enhances the efficacy of radiation therapy in lung and head and neck carcinoma.Current and Emerging Treatment Regimens for HER2-Positive Breast CancerHitting multiple targets in HER2-positive breast cancer: proof of principle or therapeutic opportunity?Does surgery for breast cancer induce angiogenesis and thus promote metastasis?Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from ⁶⁸Ga-RGD PET/CT and ¹⁸F-FDG PET/CT.The roles of neuregulin-1 in cardiac development, homeostasis, and disease.Salinomycin: A new paradigm in cancer therapy.Combination of nanotechnology with vascular targeting agents for effective cancer therapy.Positive interaction between lapatinib and capecitabine in human breast cancer models: study of molecular determinants.Integrative Analysis of mRNA, microRNA, and Protein Correlates of Relative Cerebral Blood Volume Values in GBM Reveals the Role for Modulators of Angiogenesis and Tumor Proliferation.Human epidermal growth factor receptor bispecific ligand trap RB200: abrogation of collagen-induced arthritis in combination with tumour necrosis factor blockade.
P2860
Q24796706-A3EA54F7-1F63-4EC0-9366-2987266A2DECQ24806468-169D1CEE-1DBC-40C9-A0E1-27D8F6C85610Q28067145-7AA6BD51-F3F5-4E9F-9BCB-6F94A30C4EA6Q28079224-DEEC504C-589F-401A-83C8-187FA1593244Q28661521-45217CA5-9BD6-4354-8C10-C7AFC07D5998Q30409456-73495D34-5024-4CA2-888B-762FC50188C1Q33312390-CB53D8C3-CD34-48DE-A0D8-D5B936A3FEA4Q33640753-BE7EAE5A-9664-47D0-9E95-7B05382F790CQ33688434-E46F21F6-793D-462C-BB32-646B9816F110Q33709284-989C8282-3FA8-4EC4-A46C-7498EF0BF906Q34348403-ED24CB06-C937-454C-B129-07ECB2336AABQ34508475-E61C97D2-CE13-4CBA-84D9-E2BFB2D4E396Q34974436-0782950B-B86F-4ECA-A2D7-50D0FE645711Q35250910-6D82F19B-1DC8-4A15-A8B8-290882765BB7Q35589203-5265323B-474F-4813-BA77-DB4E917CEBD6Q35615943-003946E5-F90F-4C0F-889F-E05D0107F33AQ35782469-433D8883-FD5F-42D8-A6D1-578CD57680ABQ35880395-B3C971AC-0FE3-41B8-ACA5-ABC9630F6223Q35908498-B54A6DEF-01AD-49E0-BD0B-1B8E4D66C6E0Q36069162-4027995A-F061-4DA3-913A-3F7F9786F157Q36236333-DB95850B-6F0D-4C56-88F5-60C8027D01D8Q36355817-42A741F7-5ADD-40A3-A239-FD527B8E9772Q36610892-624295B7-ABFD-4E57-895F-87F6373B05A7Q36673732-67B33E28-6E27-4E12-B866-C76701D35D17Q36689047-737E948E-F6B0-4861-B19B-627D3A1D4518Q36814331-54E06B7F-6E78-4BAE-B653-7EFD572F15F9Q36925030-D3312AE5-1746-4EEE-9F0D-9A05D572DEEBQ37100821-08E4A2D6-E145-4E88-9270-46096FAA010EQ37269081-1F7A1013-3780-4EFB-97DC-8BE60DE619B7Q37515219-F1C4EA0D-462D-40DD-A056-37C0AFB9571BQ37733237-C7622D0C-8C45-4D4C-8A33-50581C626DD3Q37826199-EF23D8DC-AB6D-4F6C-A460-431F8C5CA6B9Q37954052-68BF8722-7094-4502-B42D-3C9ACF0E591CQ38440214-1993815D-A582-4967-86E2-B7189DC4C02BQ38448410-7E6BBF67-9EC4-4263-8AD0-D23FAE49BA0CQ39204541-52A8E4BC-3AA9-4FF4-BC90-55031BCB2795Q39368839-960E188E-34ED-40E2-BAE4-351184EC39E1Q39533865-C1800387-1D5F-457A-B1F4-70BA7D3ED599Q39692548-AAAA6C99-781B-46A0-BA49-E4254FB7A12CQ39699735-7EBA7ED6-EB1F-4AF3-958F-961E530F41A3
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The role of HER2 in angiogenesis.
@ast
The role of HER2 in angiogenesis.
@en
The role of HER2 in angiogenesis.
@nl
type
label
The role of HER2 in angiogenesis.
@ast
The role of HER2 in angiogenesis.
@en
The role of HER2 in angiogenesis.
@nl
prefLabel
The role of HER2 in angiogenesis.
@ast
The role of HER2 in angiogenesis.
@en
The role of HER2 in angiogenesis.
@nl
P1433
P1476
The role of HER2 in angiogenesis.
@en
P2093
R Yarmand-Bagheri
P356
10.1016/S0093-7754(01)90279-9
P433
5 Suppl 16
P577
2001-10-01T00:00:00Z